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Background
Bernard Souiler is a rare, inherited disorder of platelet function.
Since its discovery in 1948, only 200 cases have been
reported worldwide. Like many affected individuals with
platelet disorders, those with Bernard Soulier syndrome
typically present with easy bruising and excessive bleeding in
early childhood. Bleeding is usually mucocutaneous in nature
and they exhibit nosebleeds, exaggerated bleeding from minor
injuries, and develop purpura or petechiae. These symptoms
can present at birth with prolonged bleeding from umbilical
cord cutting or, in males, excessive bleeding with circumcision.
In women, the presentation can occur around puberty with
abnormally heavy menstrual bleeding. However, some
affected individuals remain asymptomatic after birth and will
not present for diagnosis until adulthood.
Objective: We report a case with multiple episodes of
exaggerated bleeding and easy bruising along with the
workup associated with diagnostics.

14-month-old Caucasian male born via SVD at 38w3d
G3P1021 mother and non-consanguineous parentage.
Delivery was uncomplicated. Blood type O positive and he
was Coombs negative. Presented to pediatricians' office for
newborn visit he was found to have hyperbilirubinemia and
mild jaundice. Referred to the hematology/oncology clinic at 8
months for several episodes of prolonged bleeding and easy
bruising. No hematochezia, hematemesis, hematuria, oral
sores, or increased fussiness.
History of significant and prolonged bleeding with
circumcision and disproportionate bleeding. Mild bruising with
vaccines but had no hematomas at the injection site.
Mother and Father report no personal or family history of
bleeding disorders. Mom had a history of menorrhagia but
had no complications during the patient's birth. Father has a
history of Hodgkin’s Lymphoma which he completed therapy
in 2018.

Pathogenesis
The defect associated with BSS occurs at the level of platelet
adhesion. This occurs when the GPIbIX-V, a four-subunit
complex on the surface of platelets, interacts with von Willebrand
factor, which is found on the endothelium of damaged blood
vessels. When there is a defect in any one of the four subunits
that composes the GPIb-IX-V complex it is unable to bind to vWF
and platelet dysfunction occurs.
These subunits associate in the endoplasmic reticulum and then
mature in the Golgi apparatus before translocating to the cell
surface. There, the signal peptide is removed, and a matured GP
has an extracellular N-terminal that contains leucine-rich repeats,
a transmembrane helix, and a cytoplasmic tail. It is at the Nterminal that most binding of proteins occurs, including the
exposed von Willebrand Factor after a vascular injury. More
specifically, missense, nonsense, or deletion mutations have
occurred on four identified genes and their chromosomal
locations are identified as follows: GpIb-alpha gene
(chromosome 17), GpIb-beta gene (22q11.2), GpIX gene (3q21),
and GpV gene (3q29). This large variety in mutation type,
chromosome location, and subunit involvement is largely
responsible for Bernard Soulier’s varying presentations.
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CBC showed mild to moderate macrothrombocytopenia in the
setting of an otherwise normal CBC. Peripheral smear showed
large platelets without leukocyte inclusion bodies and
increased MPV with normal RBC and WBC morphology.
Subsequent visits showed normal coagulation studies (PT,
PTT, and factor 8 and 9) were all within normal limits. Due to
these normal findings the workup was narrowed down to
disorders of platelets dysfunction.
Next PFA-100 demonstrated a slowed closure time of 72
seconds (normal 89-153). While this is abnormal for BSS,
PFA-100 does not rule out mild or moderate platelet
dysfunction.
To distinguish from von Willebrand Disease, Ristocetin
Cofactor Activity was performed and revealed persistent deficit
of aggregation despite the addition of normal plasma.
A final confirmatory test was done by flow cytometry to
assess for platelet glycoprotein antibody expression. PGE
showed significantly reduced binding of monoclonal antibody
to platelet GPIb and normal binding to GPIIb/IIIa, which is
consistent with the diagnosis of BSS.

Genetic Testing

Patient Workup
Methods: We analyzed CBC, coagulation studies, platelet
aggregation assays, platelet glycoprotein expression by
flow cytometry, as well as screen both patient and
parents for relevant genes responsible for BSS.
Patient

BSS

Ref Range

CBC- Platelets

98k

20-100k

150-350k

Peripheral Smear

Large plts;
increased
MPV (12.3)

Macrothrombocytopenia

Normal
cytology
MPV

PT
PTT

10.4 seconds
36.9 seconds

Normal

9.4-12.5 sec
25.1-36.6 sec

Von Willebrand
Factor Antigen

223 IU/dL

Normal

50-230 IU/dL

Ristocetin
Cofactor Activity

265%

Elevated

51-215%

Platelet Function
Assay
Phase 1
Phase 2

72 sec (Low)
---

Elevated
Elevated

89-153 sec
<122 seconds

Coagulation
Factor Assays
Factor 8
Factor 9

112%
55%

Normal
Normal

69-143%
50-150%

Abnormal

Abnormal

Normal

Normal

Normal

Normal

Platelet
Glycoprotein
Flow Cytometry
GpIb Monoclonal
Antibody Binding
GpIIb/IIIa
Monoclonal
Antibody Binding
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Case Report

In the absence of a significant family history, a genetic workup
was done with both parents and the patient being assessed.
Mother of the patient's genetic profile showed a heterozygous
pathogenic variant on the GP9 gene with a cysteine to tyrosine
missense mutation at codon 135. Father of the patient had a
missense mutation of asparagine to serine on the same gene
at codon 61, which, significantly, is located within the leucinerich repeat domain. Functional studies of the father’s variant in
mammalian cells demonstrated significantly decreased ability
to associate with GBIb. This specific mutation has a minor
allele frequency of 0.0005077. This is in contrast to the
mother's mutation which has a minor allele frequency of
0.000005198.

Prognosis and Treatment
Those with mild to moderate disease should focus on
preventing large bleeds. For example, avoiding anti-platelet
drugs such as aspirin or NSAIDs and maintaining good dental
hygiene to avoid unnecessary dental procedures. Female
patients should consider hormonal control to prevent heavy
menstrual periods. Patients should also be educated about
what actions to take if a bleed does occur.
If a patient requires surgery or there is a life-threatening
hemorrhage, platelet transfusion will be used. However, some
may develop antibodies against the GPIb protein, as it is
technically a foreign body. Current recommendation is to use
HLA-matched or leukocyte depleted platelets. In addition,
antifibrinolytic agents can be used after surgeries to reduce
the amount of bleeding.

Platelet
Aggregation

ADP

AA

Epi

RIstocetin

BSS

N

N

N

D

VWD

N

N

N

D*

GT

D

D

D

D

Aspirin

D

D

D

D

N- normal; D- decreased; *corrected with normal plasma

Conclusion
Like many platelet adhesion disorders, the pathophysiology of
BSS can mimic the symptoms of a myriad of other syndromes.
Lab tests become extremely important to the diagnosis but, in
addition, a thorough history and genetic workup should not be
excluded. For this reason, we believe that BSS is
underdiagnosed and, therefore, under researched. For our
patient, having a genetic workup revealed two rare variants
occurring on the gene for GPIX and increased the number of
known genetic defects associated with the manifestation of
BSS.
Furthermore, genetic testing of children with prolonged
bleeding will lead to a greater understand of the inheritance
pattern associated with BSS.
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